Skip to main content
Watch Insiders
AUTLSector not reported

Autolus Therapeutics plc - ADR (AUTL) Insider Trading

In the last 90 days, 1 Autolus Therapeutics plc - ADR (AUTL) insider reported no open-market purchases and 1 sale totaling $15,682. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 2, 2026Cintia PiccinaU.S. CCO & Country Gen ManagerSale6,713$2.34$15,682

Common questions

AUTL insider trading FAQ

Are AUTL insiders buying or selling?
Over the last 90 days, AUTL insiders were net sellers, reporting $0.00 of open-market purchases and $15,682 of sales.
When was the last AUTL insider purchase?
No open-market insider purchase of Autolus Therapeutics plc - ADR stock was reported in the last 90 days.
Where does AUTL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Autolus Therapeutics plc - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.